• For Institutions

  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Dec3
Annovis Bio to Present Third-Stage Data on Parkinson's Dementia at Annual Meeting
13:01
Nov13
Annovis Bio released FY2025 9 Months Earnings on November 12 (EST), actual revenue USD 0, actual EPS USD -1.0099
04:00
Annovis Bio released FY2025 Q3 earnings on November 12 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.3699 (forecast USD -0.3766)
04:00
Nov7
Maxim Group Analyst Jason McCarthy Maintains Buy Rating on Annovis Bio
18:12
Oct14
Annovis Bio Inc. Issues Ordinary Shares to Raise $6 Million
21:20
Oct9
Annovis Bio Inc.'s Drug Buntanetap Shows Positive Biomarker Data in Alzheimer's Research
11:30

Schedules & Filings

Schedules
Filings
Nov12
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -7.263 M, EPS -0.3699

Aug12
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -6.22 M, EPS -0.32

May13
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -5.537 M, EPS -0.32

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
PETS
3.320
+87.56%
+1.540
ATPC
0.1237
+81.91%
+0.056
BTTC
6.010
+81.30%
+2.735
AXIL
8.110
+61.56%
+3.090
SMX
223.500
+52.77%
+77.200
DHIL
170.060
+44.76%
+52.580
BEAT
2.225
+43.55%
+0.660
GEMG
9.060
+42.38%
+2.697
MIGI
9.245
+37.99%
+2.540
PL
17.445
+34.81%
+4.501
View More